Clincosm LogoSign in Get a demo

Hepatocellular Carcinoma

Showing NaN - NaN of 51
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer, Hepatocellular Carcinoma, Melanoma Trial in United States (MT-8421, Nivolumab)

Recruiting
  • Non Small Cell Lung Cancer
  • +10 more
  • Los Angeles, California
  • +4 more
Sep 5, 2023

Advanced Solid Tumor, Hepatocellular Carcinoma Trial in Los Angeles (TORL-4-500)

Not yet recruiting
  • Advanced Solid Tumor
  • Hepatocellular Carcinoma
  • Los Angeles, California
    UCLA - JCCC Clinical Research Unit
Aug 23, 2023

Hepatocellular Carcinoma Trial in Worldwide (Budigalimab, Livmoniplimab, Lenvatinib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Prescott Valley, Arizona
  • +58 more
Apr 10, 2023

Hepatocellular Carcinoma, Liver Metastases, Cholangiocarcinoma Trial in United States (STP705)

Active, not recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Scottsdale, Arizona
  • +4 more
Dec 13, 2022

Multiple Myeloma, DLBCL, Glioblastoma Multiforme Trial in Worldwide (CC-223)

Completed
Has Results
  • Multiple Myeloma
  • +6 more
  • Los Angeles, California
  • +15 more
Dec 9, 2022

Hepatocellular Carcinoma, Nonalcoholic Steatohepatitis Trial in Tarzana, New York, Durham (Lisinopril, Questionnaire

Recruiting
  • Hepatocellular Carcinoma
  • Nonalcoholic Steatohepatitis
  • Biospecimen Collection
  • +6 more
  • Los Angeles, California
  • +3 more
Dec 8, 2022

Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)

Completed
  • Melanoma
  • +27 more
  • XmAb20717
  • Los Angeles, California
  • +16 more
Nov 29, 2022

Pancreatic Cancer, Small Bowel Cancer, Colorectal Cancer Trial in United States (Ulixertinib (BVD-523))

Available
  • Pancreatic Cancer
  • +20 more
  • Ulixertinib (BVD-523)
  • Birmingham, Alabama
  • +25 more
Nov 4, 2022

Breast Cancer, Colorectal Cancer, Ovarian Cancer Trial in United States (ATRC-101, Pembrolizumab, Pegylated liposomal

Recruiting
  • Breast Cancer
  • +15 more
  • ATRC-101
  • +2 more
  • Phoenix, Arizona
  • +10 more
Sep 28, 2022

Hepatocellular Carcinoma, Unresectable Hepatocellular Carcinoma Trial in United States (Cisplatin, Doxorubicin Hydrochloride,

Active, not recruiting
  • Hepatocellular Carcinoma
  • Unresectable Hepatocellular Carcinoma
  • Birmingham, Alabama
  • +280 more
Sep 23, 2022

Soft Tissue Sarcoma, Renal Cell Carcinoma, Uterine Carcinosarcoma Trial in United States (HFB301001)

Recruiting
  • Soft Tissue Sarcoma
  • +4 more
  • Scottsdale, Arizona
  • +9 more
Sep 13, 2022

Gastric Cancer, Hepatocellular Carcinoma Trial in Beverly Hills, Los Angeles, Torrance (Telatinib, Keytruda)

Recruiting
  • Gastric Cancer
  • Hepatocellular Carcinoma
  • Beverly Hills, California
  • +3 more
Sep 1, 2022

Solid Tumor, Cancer, Carcinoma Trial in United States (Mogamulizumab + Nivolumab)

Completed
Has Results
  • Solid Tumor
  • +4 more
  • Mogamulizumab + Nivolumab
  • Gilbert, Arizona
  • +14 more
Jul 27, 2022

Advanced Solid Tumor, Clear Cell Renal Cell Carcinoma, Hepatocellular Carcinoma Trial in Korea, Republic of, Singapore, United

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Duarte, California
  • +22 more
Aug 17, 2022

Hepatocellular Carcinoma Trial in Worldwide (Pembrolizumab, Regorafenib (Stivarga, BAY73-4506))

Active, not recruiting
  • Hepatocellular Carcinoma
  • Tucson, Arizona
  • +38 more
Aug 1, 2022

Multi- Target Hepatocellular Carcinoma Test in Increased Risk

Recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Study CT/MRI Imaging
  • +2 more
  • Chandler, Arizona
  • +33 more
May 27, 2022

Adrenal Cortex Carcinoma, Alveolar Soft Part Sarcoma, CNS Tumor Trial in United States (Cabozantinib, Cabozantinib S-malate,

Active, not recruiting
  • Adrenal Cortex Carcinoma
  • +39 more
  • Birmingham, Alabama
  • +142 more
May 24, 2022

Advanced Hepatocellular Carcinoma, Hepatocellular Carcinoma, Liver Cancer Trial in Worldwide (H3B-6527)

Completed
  • Advanced Hepatocellular Carcinoma
  • +5 more
  • Los Angeles, California
  • +43 more
Apr 5, 2022

Hepatocellular Carcinoma Trial in United States (BBI608, BBI503, Sorafenib)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Gilbert, Arizona
  • +28 more
Apr 4, 2022

NSCLC, Small Cell Lung Cancer, Urothelial Carcinoma Trial in United States (N-803 + Pembrolizumab, N-803 + Nivolumab, N-803 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • N-803 + Pembrolizumab
  • +9 more
  • Anchorage, Alaska
  • +34 more
Apr 4, 2022

Ovarian Cancer, Hepatocellular Carcinoma, NSCLC Trial in Canada, United States (DPX-Survivac, Cyclophosphamide, Pembrolizumab)

Active, not recruiting
  • Ovarian Cancer
  • +4 more
  • DPX-Survivac
  • +2 more
  • Tucson, Arizona
  • +22 more
Mar 28, 2022

Hepatocellular Carcinoma Trial in Worldwide (Durvalumab, Tremelimumab (Regimen 1), Tremelimumab (Regimen 2))

Recruiting
  • Hepatocellular Carcinoma
  • Los Angeles, California
  • +173 more
Mar 25, 2022

Hepatocellular Carcinoma Trial in Worldwide (Ramucirumab, Placebo)

Completed
Has Results
  • Hepatocellular Carcinoma
  • Daly City, California
  • +130 more
Jan 5, 2022

Hepatocellular Carcinoma Trial in Worldwide (Nivolumab, Sorafenib, Ipilimumab)

Active, not recruiting
  • Hepatocellular Carcinoma
  • Nivolumab
  • +3 more
  • Los Angeles, California
  • +58 more
Dec 1, 2021

Hepatocellular Carcinoma Trial in Worldwide (HepaSphere/QuadraSphere Microspheres, PVA, lipiodol, doxorubicin)

Terminated
Has Results
  • Hepatocellular Carcinoma
  • HepaSphere/QuadraSphere Microspheres
  • PVA, lipiodol, doxorubicin
  • Birmingham, Alabama
  • +22 more
Nov 2, 2021